| P50 | author | Michael A. Freitas | Q42850531 |
| | Jennifer Thomas-ahner | Q42765701 |
| | Sean Harshman | Q42777882 |
| P2093 | author name string | Steven K Clinton | |
| | David M Lucas | |
| | John C Byrd | |
| | Rajbir Singh | |
| | Mark R Parthun | |
| | Amir Mortazavi | |
| | Amy S Ruppert | |
| P2860 | cites work | Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma | Q43159478 |
| | Global histone modification patterns predict risk of prostate cancer recurrence | Q46162501 |
| | Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. | Q52832871 |
| | Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer | Q63979896 |
| | Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer | Q63979898 |
| | Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma | Q83594538 |
| | Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma | Q84650957 |
| | Nucleolar proteome dynamics | Q21735921 |
| | Increasing the complexity of chromatin: functionally distinct roles for replication-dependent histone H2A isoforms in cell proliferation and carcinogenesis | Q24318614 |
| | K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas | Q24615283 |
| | The human H2A and H2B histone gene complement | Q28138093 |
| | The human and mouse replication-dependent histone genes | Q28212439 |
| | Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer | Q28239595 |
| | Testis-specific expression of a novel human H3 histone gene | Q28300716 |
| | Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma | Q29616862 |
| | Global histone modifications predict prognosis of resected non small-cell lung cancer. | Q33300936 |
| | Alterations of global histone H4K20 methylation during prostate carcinogenesis | Q34194181 |
| | Assaying pharmacodynamic endpoints with targeted therapy: flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia | Q34493326 |
| | Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia | Q35025733 |
| | TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. | Q36001319 |
| | High-sensitivity TFA-free LC-MS for profiling histones | Q36453034 |
| | Quantitative profiling of histone post-translational modifications by stable isotope labeling | Q36948637 |
| | Global levels of histone modifications predict prognosis in different cancers | Q37164151 |
| | An H2A histone isotype regulates estrogen receptor target genes by mediating enhancer-promoter-3'-UTR interactions in breast cancer cells | Q37631879 |
| | Targeting histone modifications--epigenetics in cancer | Q38076536 |
| | Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma | Q38259785 |
| | Alterations of histone H1 phosphorylation during bladder carcinogenesis | Q39151691 |
| | Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma | Q39839862 |
| | Global levels of histone modifications predict prostate cancer recurrence. | Q39899696 |
| | Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. | Q42452150 |
| P433 | issue | 1 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 22 | |
| P577 | publication date | 2015-08-27 | |
| P1433 | published in | Clinical Proteomics | Q5133793 |
| P1476 | title | Proteomic profiling identifies specific histone species associated with leukemic and cancer cells | |
| P478 | volume | 12 | |